Panagene Will Supply AdvanDx With PNA Probes for Its IVDs | GenomeWeb
NEW YORK (GenomeWeb News) — AdvanDx today said it will buy peptide nucleic acid probes from Panagene for use in its PNA FISH in vitro diagnostics.
 
AdvanDx’s molecular-based tests identify bacteria species associated with bloodstream infections from blood cultures. Panagene’s PNA probes target specific RNA in the bacteria, AdvanDx said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.